Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. 2001

R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
L'Institut Cardiovasculaire, Paris, France.

BACKGROUND Epidemiological studies have shown that increased arterial stiffness and wave reflections, major determinants of systolic and pulse pressure, are associated with morbidity and mortality. Therapeutic trials based on cardiovascular mortality have recently shown that reduction of systolic blood pressure (SBP) requires normalization of both large-artery stiffness and wave reflections. OBJECTIVE To compare the antihypertensive effects of the very-low-dose combination of perindopril (2 mg) and indapamide (0.625 mg) (one or two tablets per day) with the beta-blocking agent atenolol (50 mg; one or two tablets per day) in order to determine whether the combination decreased SBP and pulse pressure more than did atenolol, and whether this decrease occurred in relation to a reduction in arterial stiffness [aortic pulse wave velocity (PWV)] or a decrease in the intensity of, or delay in, wave reflections (augmentation index, measured by applanation tonometry) or a combination of both. METHODS This was a double-blind randomized study in 471 individuals with essential hypertension followed for 12 months. Arterial pressure was measured in the brachial artery (mercury sphygmomanometer) and in the carotid artery (applanation tonometry). RESULTS For the same reduction in diastolic blood pressure (DBP), the combination of perindopril and indapamide decreased brachial SBP and pulse pressure significantly more than did atenolol (adjusted differences between groups -6.2 +/- 1.5 and -5.5 +/- 1.0 mmHg, respectively; P < 0.001). This difference was even more pronounced for the carotid than for the brachial artery. Whereas both antihypertensive agents similarly decreased PWV, only the combination significantly attenuated wave reflections. CONCLUSIONS Normalization of SBP, pulse pressure and arterial function--a haemodynamic profile known to improve survival significantly in hypertensive populations at high cardiovascular risk--was achieved to a greater extent with a very-low-dose combination of perindopril and indapamide than with atenolol.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007190 Indapamide A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. Metindamide,S-1520,SE-1520,S 1520,S1520,SE 1520,SE1520
D001916 Brachial Artery The continuation of the axillary artery; it branches into the radial and ulnar arteries. Arteries, Brachial,Artery, Brachial,Brachial Arteries
D002339 Carotid Arteries Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. Arteries, Carotid,Artery, Carotid,Carotid Artery
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001158 Arteries The vessels carrying blood away from the heart. Artery
D014655 Vascular Resistance The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT. Peripheral Resistance,Total Peripheral Resistance,Pulmonary Vascular Resistance,Systemic Vascular Resistance,Peripheral Resistance, Total,Resistance, Peripheral,Resistance, Pulmonary Vascular,Resistance, Systemic Vascular,Resistance, Total Peripheral,Resistance, Vascular,Vascular Resistance, Pulmonary,Vascular Resistance, Systemic

Related Publications

R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
November 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
August 1999, Drugs,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
January 2011, Likars'ka sprava,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
March 1999, Journal of human hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
June 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
September 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
January 2011, Terapevticheskii arkhiv,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
September 1998, American journal of hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
March 2000, Journal of hypertension,
R G Asmar, and G M London, and M E O'Rourke, and J M Mallion, and R Romero, and K H Rahn, and B Trimarco, and D Fitzgerald, and T Hedner, and D Duprez, and P W De Leeuw, and P Sever, and E Battegay, and G Hitzenberger, and N de Luca, and P Polónia, and A Bénétos, and C Chastang, and J P Ollivier, and M E Safar, and
October 2014, Revue medicale de Liege,
Copied contents to your clipboard!